BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  CytoSorbents to Present at the Stifel, Jefferies, and Canaccord Investor Conferences This Week

  CytoSorbents Corporation (NASDAQ: CTSO), announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, and Chief Financial Officer, Ms. Kathleen Bloch, MBA will separately present an overview of the company at multiple healthcare conferences this week.

  November 12, 2018

   · 

  5 min read
• BioMidwest

  Morningstar’s Second Annual Assessment of the 10 Largest Health Savings Account Plans Finds Investment Quality Has Improved but High Fees and Lack of Transparency Remain Hurdles

  Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today published its second annual study assessing plans from 10 of the largest Health Savings Account (HSA) plan providers.

  November 12, 2018

   · 

  5 min read
• Drug Development

  KalVista Pharmaceuticals Provides Clinical Update on KVD900

  Enlarged Phase 2 Study to Begin in 2018 for Potential Acute Treatment of Hereditary Angioedema; Data Expected in Late 2019

  November 12, 2018

   · 

  4 min read
• Policy

  Avandia drug Canada-wide settlement reached

  The Avandia drug class action lawsuit has reached a Canada-wide settlement

  November 12, 2018

   · 

  1 min read
• Business

  CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET

  China Pharma Holdings, Inc. today announced that it plans to hold its third quarter 2018 earnings conference call on Thursday, November 15, 2018 at 8:30 a.m. ET.

  November 12, 2018

   · 

  1 min read
• Job Trends

  Extinktion Removes Unwanted Hair and Tattoos in Grand Forks, North Dakota Featuring the Astanza ReSmooth and Duality Lasers

  Extinktion clinic has invested in the Astanza ReSmooth laser to deliver long-lasting, permanent hair reduction and the Astanza Duality to provide complete tattoo removal, selective tattoo removal, and tattoo lightening for cover-ups.

  November 12, 2018

   · 

  2 min read
• Business

  BridgeBio Pharma LLC Signs Joint Collaboration Agreement with Cincinnati Children’s to Accelerate Development of Genetic Disease Therapeutics

  BridgeBio Pharma LLC and Cincinnati Children’s Hospital Medical Center today announced they are entering into a research collaboration to identify and develop genetic disease therapies.

  November 12, 2018

   · 

  2 min read
• Pharm Country

  Johnson & Johnson to Participate in the Citi’s 2018 Global Healthcare Conference

  Johnson & Johnson will participate in the Citi’s 2018 Global Healthcare Conference on Wednesday, December 5th, at the Lotte New York Palace Hotel in New York City.

  November 12, 2018

   · 

  1 min read
• Genetown

  Data from Axcella’s AXA1125 Program Supports New Approach Leveraging Endogenous Metabolic Modulators to Reprogram Cellular Physiology

  AXA1125 was safe and well tolerated with impact on liver function biomarkers of metabolism, inflammation, and fibrosis

  November 12, 2018

   · 

  3 min read
• Business

  Singapore National Eye Centre, Singapore Eye Research Institute And Johnson & Johnson Vision Set Sights On Halting Global Myopia Epidemic

  New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition

  November 12, 2018

   · 

  8 min read